Contribution: Industrial Research Assistance Program
Reverb Therapeutics Inc.
$378,600.00
Design and development of antibodies for modulation of regulatory T-cell activity with application in auto-immune diseases
FY 2025-26 · 2025-07-01
Summary
The project will design and evaluate various antibodies that can redirect and deliver endogenous cytokine to regulatory T-cells to induce selective activation and proliferation of these immune regulatory cells.
Department
Program
Industrial Research Assistance Program
Recipient
Location
Vancouver|Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
748263746
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2025-07-01 | 2025-26 | $338,200.00 |
| 1 | 2025-07-01 | 2025-26 | $378,600.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 123 days. The total amended value is 40,400 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 123 jours. La valeur totale des modifications est de 40 400 dollars.
Agreement End Date
2027-02-28
Agreement Number
1033298
Agreement Start Date
2025-07-01
Agreement Title
Design and development of antibodies for modulation of regulatory T-cell activity with application in auto-immune diseases
Agreement Title (French)
Conception et développement d’anticorps pour la modulation de l’activité des lymphocytes T régulateurs dans le cadre de maladies auto-immunes
Agreement Type
Contribution
Agreement Value
$378,600.00
Amendment Date
2026-07-07
Amendment Number
1
Coverage
Industrial Research Assistance Program projects stimulate wealth creation for Canada through technological innovation and strengthen Canadian innovation ecosystem by creating new industrial capacity. | Les projets du Programme d'aide à la recherche industrielle favorisent la création de richesse au Canada grâce à l'innovation technologique et renforcent l'écosystème canadien de l'innovation en créant de nouvelles capacités industrielles.
Description
The project will design and evaluate various antibodies that can redirect and deliver endogenous cytokine to regulatory T-cells to induce selective activation and proliferation of these immune regulatory cells.
Description (French)
Le projet consistera à concevoir et à évaluer divers anticorps capables de rediriger et de délivrer des cytokines endogènes aux lymphocytes T régulateurs afin d’induire l’activation et la prolifération sélectives de ces cellules immunitaires régulatrices.
Expected Results
The expected results and outcomes of NRC Industrial Research Assistance Program is focused on growing small and medium-sized enterprises (SMEs) through innovation and wealth creation for Canada.
Expected Results (French)
Les résultats attendus du Programme d’aide à la recherche industrielle du CNRC sont axés sur la croissance des petites et moyennes entreprises (PME) grâce à l’innovation et à la création de richesse pour le Canada.
Federal Riding
Vancouver Centre
Federal Riding (French)
Vancouver-Centre
Federal Riding Number
59035
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program
Program Name (French)
Programme d’aide à la recherche industrielle
Program Purpose
The purpose of Industrial Research Assistance Program Contributions to Firms is to provide support that assists small and medium-sized enterprises (SMEs) to advance their innovation knowledge and ability to innovate, grow through innovation and stimulate wealth creation for Canada.
Program Purpose (French)
Les contributions versées aux entreprises en vertu du Programme d’aide à la recherche industrielle ont pour objectif d’apporter un soutien aux petites et moyennes entreprises (PME) afin qu’elles puissent approfondir leurs connaissances en matière d’innovation et renforcer leur capacité d’innovation, de croissance et de création de richesse pour le Canada.
Recipient Business Number
748263746
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
Reverb Therapeutics Inc.
Recipient Postal Code
V7Y 1B3
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2025-2026-Q2-1033298
